HK1129075A1 - Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same - Google Patents

Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same

Info

Publication number
HK1129075A1
HK1129075A1 HK09109192.8A HK09109192A HK1129075A1 HK 1129075 A1 HK1129075 A1 HK 1129075A1 HK 09109192 A HK09109192 A HK 09109192A HK 1129075 A1 HK1129075 A1 HK 1129075A1
Authority
HK
Hong Kong
Prior art keywords
von willebrand
factor
willebrand factor
complex
concentrate
Prior art date
Application number
HK09109192.8A
Other languages
English (en)
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39316136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1129075(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of HK1129075A1 publication Critical patent/HK1129075A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
HK09109192.8A 2008-01-08 2009-10-05 Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same HK1129075A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200800021A ES2298096B1 (es) 2008-01-08 2008-01-08 Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.

Publications (1)

Publication Number Publication Date
HK1129075A1 true HK1129075A1 (en) 2009-11-20

Family

ID=39316136

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109192.8A HK1129075A1 (en) 2008-01-08 2009-10-05 Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same

Country Status (17)

Country Link
US (2) US8354505B2 (es)
EP (1) EP2078730B9 (es)
JP (1) JP4976366B2 (es)
CN (1) CN101480490B (es)
AR (1) AR072441A1 (es)
AT (1) ATE509031T1 (es)
AU (1) AU2008255137C1 (es)
BR (1) BRPI0900057B8 (es)
CA (1) CA2645701C (es)
CL (1) CL2009000022A1 (es)
ES (2) ES2298096B1 (es)
HK (1) HK1129075A1 (es)
MX (1) MX2008015892A (es)
NZ (1) NZ573400A (es)
PL (1) PL2078730T3 (es)
PT (1) PT2078730E (es)
RU (1) RU2417096C2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
CN101952016A (zh) 2007-12-28 2011-01-19 巴克斯特国际公司 重组vwf配方
AU2009307648C1 (en) 2008-10-21 2016-12-08 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
FI3858375T3 (fi) * 2011-06-10 2024-04-17 Takeda Pharmaceuticals Co Hyytymishäiriön hoito antamalla rekombinanttia von Willebrand -tekijää
EP2725033B1 (en) * 2011-06-24 2017-08-09 Asahi Kasei Medical Co., Ltd. Method for producing protein preparation
WO2013106787A1 (en) 2012-01-12 2013-07-18 Biogen Idec Ma Inc. Chimeric factor viii polypeptides and uses thereof
EP2841451A1 (en) 2012-04-24 2015-03-04 Novo Nordisk A/S Compounds suitable for treatment of haemophilia
AU2014346343B2 (en) * 2013-11-08 2018-05-10 Csl Ltd. New method to concentrate von Willebrand factor or complexes thereof
WO2015185758A2 (en) * 2014-06-06 2015-12-10 Octapharma Ag Preparation comprising factor viii and von willebrand factor peptides
CN104804078B (zh) * 2015-05-05 2019-01-04 广东卫伦生物制药有限公司 人体血清凝血因子ⅷ中的病毒过滤方法
KR20200038309A (ko) * 2017-08-23 2020-04-10 체에스엘 베링 게엠베하 폰 빌레브란트 인자의 바이러스 여과 방법
EP4384205A1 (en) 2021-08-11 2024-06-19 Grifols Worldwide Operations Limited Method for producing human plasma-derived factor viii / von willebrand factor and composition obtained

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
US5288853A (en) 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
EP0860444A1 (en) * 1997-02-24 1998-08-26 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis (CLB) Method for removing viruses from a protein solution
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu

Also Published As

Publication number Publication date
CA2645701A1 (en) 2009-07-08
RU2008151957A (ru) 2010-07-10
CN101480490A (zh) 2009-07-15
ATE509031T1 (de) 2011-05-15
JP2009161528A (ja) 2009-07-23
US20090176709A1 (en) 2009-07-09
RU2417096C2 (ru) 2011-04-27
BRPI0900057B8 (pt) 2021-06-29
AU2008255137B2 (en) 2011-04-07
BRPI0900057A2 (pt) 2009-09-22
US8354505B2 (en) 2013-01-15
US20110275570A1 (en) 2011-11-10
ES2298096A1 (es) 2008-05-01
CN101480490B (zh) 2013-05-29
PT2078730E (pt) 2011-07-14
CA2645701C (en) 2013-09-17
BRPI0900057B1 (pt) 2021-03-23
JP4976366B2 (ja) 2012-07-18
PL2078730T3 (pl) 2011-10-31
CL2009000022A1 (es) 2009-11-20
ES2298096B1 (es) 2009-01-01
AU2008255137C1 (en) 2015-08-27
NZ573400A (en) 2010-02-26
AU2008255137A1 (en) 2009-07-23
ES2363827T3 (es) 2011-08-17
EP2078730A1 (en) 2009-07-15
AR072441A1 (es) 2010-09-01
MX2008015892A (es) 2009-07-07
EP2078730B9 (en) 2011-12-21
EP2078730B1 (en) 2011-05-11

Similar Documents

Publication Publication Date Title
HK1129075A1 (en) Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same
AU2018200946B2 (en) Method and system for removing carbon dioxide from hydrocarbons
EA201790508A1 (ru) Мембраны гемодиализа и гемофильтрации на основе двумерного мембранного материала и способы их применения
DE602007010908D1 (de) Verfahren zur herstellung von wässrigen dispersionen von tio2 in form von nanopartikeln und danach erhältliche dispersionen
MY159511A (en) Process of direct copper exchange into na+-form of chabazite molecular sieve, and catalysts, systems and methods
UA100901C2 (ru) Способ очищения фактора свертывания крови viii
CA2792357C (en) Porous hollow fiber membrane for treatment of protein-containing liquid
MY161726A (en) Biological methods for preparing adipic acid
GB2441939A (en) Surgical membrane
WO2010043914A3 (en) Water purification method
MX2013003612A (es) Proceso de filtracion de membrana con alta recuperacion de agua.
WO2015038984A3 (en) Modified anti-epidermal growth factor receptor antibodies and methods of use thereof
WO2009083011A3 (en) A method for dialysis fluid regeneration
ATE490292T1 (de) Verfahren zur delaminierung von aggregierten partikeln mit einem beschichtungsmittel in einem überkritischen fluid
EP1733784A4 (en) POLYSULFONE PERMSELECTIVE HOLLOW FIBER MEMBRANE BEAM AND PROCESS FOR PRODUCING THE SAME
ATE322252T1 (de) Verfahren zur herstellung und sammlung von kristallinen partikeln
DE602007004003D1 (de) Verfahren zur fertigung von kegelrädern zwecks herstellung einer diffusen oberflächenstruktur
IN2015DN00652A (es)
MY161039A (en) Apparatus and method for producing catalyst, and method for producing unsaturated acid or unsaturated nitrile
CN205164520U (zh) 一种多层复合中空纤维膜
DE502005004235D1 (de) Verfahren zur Herstellung von Durchzügen in Sammelrohren und Vorrichtung zur Durchführung des Verfahrens
DE602006012425D1 (de) Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle
WO2009021588A3 (de) Mischung aus filterhilfsmitteln zur verwendung bei der anschwemmfiltration sowie verfahren zur anschwemmfiltration von flüssigkeiten
DE50209881D1 (de) Herstellung von dialysekonzentrat aus einer hochverdichteten konzentratvorstufe und vorrichtung zur anwendung am dialyseplatz.
DE602004021995D1 (de) Niedrige konzentrierte wässrige Lösung zur Behandlung von Kunstofffasern, Verfahren zu ihrer Herstellung und Verfahren zur Behandlung von Kunstofffasern

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201209